Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.1K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.1K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

833
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
833
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

959
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
959
Anatomy of the Eyeball01:20

Anatomy of the Eyeball

8.9K
The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
8.9K
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.4K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

8.0K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Decoding the rising trend of presenile cataracts in the post-COVID era - Indian scenario.

Indian journal of ophthalmology·2026
Same author

Canada's National Advisory Committee on Immunization (NACI) in 2025: Celebrating 60 years of service, a decade of change, and a dynamic future ahead.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2026
Same author

Genetically distinct Hajj and South American-related strains of serogroup W Neisseria meningitidis causing invasive meningococcal disease in Ontario, Canada, January 1, 2015 to June 30, 2024.

Journal of infection and public health·2025
Same author

Impact of the COVID-19 pandemic on routine immunization coverage of children and teenagers in Ontario, Canada.

Vaccine·2025
Same author

Strategies and resources used by public health units to encourage COVID-19 vaccination among priority groups: a behavioural science-informed review of three urban centres in Canada.

BMC public health·2025
Same author

Summary of the National Advisory Committee on Immunization (NACI) Statement: Updated guidance on human papillomavirus (HPV) vaccines.

Canada communicable disease report = Releve des maladies transmissibles au Canada·2024

Related Experiment Video

Updated: Nov 25, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.8K

Atypical optic neuritis: An overview.

Prathama Sarkar1, Amit Mehtani1, H C Gandhi1

  • 1Department of Ophthalmology, Deen Dayal Upadhyay Hospital, New Delhi, India.

Indian Journal of Ophthalmology
|December 16, 2020
PubMed
Summary

Atypical optic neuritis involves optic nerve inflammation. Identifying autoantibodies and biomarkers aids neurologists and ophthalmologists in diagnosing and managing this condition.

Keywords:
Atypical optic neuritisinfectious optic neuritismyelin oligodendrocyte glycoprotein antibodyneuromyelitis opticaoptic neuritis

More Related Videos

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION
06:49

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION

Published on: November 20, 2016

9.1K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.4K

Related Experiment Videos

Last Updated: Nov 25, 2025

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

11.8K
The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION
06:49

The Rodent Model of Nonarteritic Anterior Ischemic Optic Neuropathy rNAION

Published on: November 20, 2016

9.1K
Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients
12:23

Dynamic Visual Tests to Identify and Quantify Visual Damage and Repair Following Demyelination in Optic Neuritis Patients

Published on: April 14, 2014

14.4K

Area of Science:

  • Neuroscience
  • Immunology
  • Ophthalmology

Background:

  • Optic neuritis (ON) is characterized by inflammation of the optic nerve.
  • Autoantibodies are linked to central nervous system inflammatory disorders, offering insights into atypical ON.
  • Understanding immune targets and mechanisms is crucial for prognosis, treatment, and recurrence of ON.

Purpose of the Study:

  • To review the current understanding of atypical optic neuritis.
  • To discuss the clinical management strategies for atypical ON.

Main Methods:

  • Literature review of studies on optic neuritis, autoantibodies, and biomarkers.
  • Analysis of clinical, laboratory, and imaging findings relevant to atypical ON.

Main Results:

  • Autoantibodies provide critical information regarding immune targets and mechanisms in atypical ON.
  • Biomarkers are essential for confirming and differentiating atypical ON from other conditions.

Conclusions:

  • Multidisciplinary collaboration between neurologists and ophthalmologists is vital.
  • Identifying clinical, laboratory, and imaging clues is key for determining the etiology and management of atypical ON.